Alan Kotok (right) asks question on science entrepreneurship at a news conference put on by the Science Coalition and Association of American Universities, 9 July 2014. See Panel: Federal Science Cuts Hurt U.S. Competitiveness. (Science Coalition)
Technology News and Literature provides quality news reporting on the intersection of science, technology, business, and public policy. This site provides links to current and previous work, including online services, books, articles, white papers, and photography.
- LinkedIn. Job Loyalty Revisited: Earned, not Entitled. 7 September 2014. Employers face the challenge of creating an environment where job security and career advancement are more the norm than the exception. Career advancement is something managers at all levels can provide, and often without incurring much expense.
- LinkedIn. Job Loyalty Revisited: Lessons from Market Basket. 1 September 2014. For American workers, the Market Basket story should raise a few questions about loyalty owed to an employer, and restoring some of the balance that seems weighted way in favor of the people signing pay checks.
- Seeking Alpha. Sanofi Bolsters Vaccine Business. 18 August 2014. Sanofi Pasteur, the pharmaceutical company's vaccines division, has important new releases coming up in late-stage clinical trials and for regulatory review.
- Seeking Alpha. Shire Acquisition Bolsters Its Rare, And Maybe Not-So-Rare, Disease Portfolio. 19 May 2014. The acquisition by Shire plc earlier this month of Lumena Pharmaceuticals builds Shire's already strong position in rare diseases, but the acquisition can also help Shire advance drug development programs aimed at larger populations.
- LinkedIn. My Mission: Journalists Who Love Math. 26 April 2014. For too many reporters of all kinds, covering a story with any amount of quantification seems to make them surrender to the words in a press release. I'm on a mission to change that.
- Seeking Alpha. New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy. 21 April 2014. A diabetes drug approved last week for sale in the U.S. and Europe brings GlaxoSmithKline (GSK) into a new therapy field for the company, one that is both crowded and changing rapidly with the ageing of baby boomers and new directions in health care.
- Seeking Alpha. Myriad Genetics' Acquisition Of Crescendo Bioscience: A Question Of Timing. 10 February 2014. "At first glance, the acquisition makes a lot of sense for Myriad, adding a ready-made capability in a complementary line, but also this week, the scientific landscape changed markedly for rheumatoid arthritis and similar disorders, adding a wrinkle into Myriad's plans for the company."
- Seeking Alpha. Bayer's Curious Acquisition Of Cancer Drug Maker Algeta. 23 December 2013. News of the acquisition stressed Bayer's getting "outright control" of Algeta's drug for advanced prostate cancer through the acquisition, but a look at Algeta's technology suggests Bayer is getting more for its $2.9 billion than a single drug it already markets.
- Seeking Alpha. Walgreen's Mobile Strategy Scores With Retail Customers. 30 July 2013. Walgreen's mobile strategy is paying off in higher sales volume for mobile customers than store-only customers, but wellness apps are a different world for a company that's still essentially a drug store chain.
- E-book: Cienfuegos Rainbow: Observations of a 21st Century Cuba. April 2013. An eight-day study tour of Cuba became an eye-opening experience that highlighted a country struggling to feed and house its population in the 21st century, while stuck in a confrontational cold war past. Alan and Sharon Kotok describe their experiences as part of a group of University of Iowa alumni who visited Cuba in January 2013.